HUM241206C310000
- 0.20
- -0.36-64.29%
Humana Newsroom
Humana Taps Global Infrastructure Partners Finance Chief as CFO -- 2nd Update
Humana (HUM) Stock Falls on News of CFO Departure
Humana has announced that the chief financial officer will step down in January next year.
Grain Stream December 3rd | Humana announced on Tuesday that the company's Chief Financial Officer Susan Diamond will step down on January 11th and serve as a consultant until the end of 2025 to ensure a smooth transition for the company. This personnel change comes as the medical insurance company is working to manage medical costs associated with large business Medicare Advantage insurance plans, leading to the company withdrawing its profit forecast for 2025 in April. Currently serving as Blackrock's recently acquired infrastructure fund manager.
Humana Says Susan Diamond to Step Down as CFO
Humana Taps Celeste Mellet as New CFO
Humana Announces Leadership Change and Reaffirms 2024 EPS Guidance
Humana: Celeste Mellet To Succeed Susan Diamond As CFO; Reiterates 2024 Adj. EPS Guidance
Humana Names New CFO, Reiterates Annual Profit Forecast
Express News | Humana Inc - Celeste Mellet to Receive $975,000 Base Salary and $6 Mln Equity Award
Humana: Mellet Currently Serves as CFO of Global Infrastructure Partners >HUM
Express News | Humana Inc FY2024 Shr View $16.15 -- LSEG IBES Data
Express News | Humana Inc - Reiterates 2024 Adjusted EPS Guidance of at Least $16.00
Express News | Humana Inc - Susan Diamond Steps Down as CFO, to Serve as Advisor Through 2025
Express News | Humana Inc - Appoints Celeste Mellet as CFO Effective January 11, 2025
Express News | Humana Announces CFO Transition
Blue Shield of California Appoints Ellen Sexton as Chief Growth Officer
Humana (NYSE:HUM) Will Pay A Dividend Of $0.885
The Trump economic team may have internal discord, and the key agenda still needs the "understanding king" to make the final decision!
Analysts state that the Trump team's characterization of the economic policy as 'the opponent team' is almost accurate, and the strong opposition between Besant and Lutnik has been publicly reported.
Why Is Humana Inc. (HUM) Among the Worst Performing Healthcare Stocks in 2024?
COPILOT PROUDLY ANNOUNCES THE RETURN OF ANNE CHIOTTI AS EXECUTIVE PHARMACIST